Locals near a needle exchange site in a Bronx park are cheering a councilman’s proposal to require city health workers to collect hundreds of discarded syringes littering the ground. Oswald ...
It’s two years since Novartis got its Cosentyx IL-17 drug approved for the spinal disease ankylosing spondylitis, and the Swiss pharma company has new data that it hopes will allow it to compete ...
The BE RADIANT trial pitted bimekizumab against Novartis’ Cosentyx (secukinumab) in the treatment of adults with moderate-to-severe psoriasis, and according to UCB is the first study to compare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback